Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Egle

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
Cancer Treatment Reviews|August 20, 2018
Remission maintenance treatment options in chronic lymphocytic leukemiaAlexander Egle, Lisa Pleyer, Thomas Melchardt, et al.
Cell Cycle (Georgetown, Tex.)|June 29, 2010
Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemiaOlaf Merkel, Daniela Asslaber, Josefina D Piñón, et al.
Discovery Medicine|October 17, 2009
Novel therapeutics approaches to chronic lymphocytic leukemia based on recent biological insightsTanja N Hartmann, Lisa Pleyer, Petra Desch, et al.
Blood|August 28, 2014
How does lenalidomide target the chronic lymphocytic leukemia microenvironment?Arnon P Kater, Sanne H Tonino, Alexander Egle, et al.
Cancer|April 28, 2011
Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemiaLukas Weiss, Thomas Melchardt, Alexander Egle, et al.
Wiener Klinische Wochenschrift|December 7, 2010
An uncommon cause of anaemia: Sheehan's syndromeThomas Melchardt, Konrad Namberger, Lukas Weiss, et al.
Blood|November 25, 2003
VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasiaAlexander Egle, Alan W Harris, Mary L Bath, et al.
Annals of Hematology|December 28, 2012
Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patientNinon Taylor, Thomas Melchardt, Michael Grundbichler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Fluorouracil and Dihydropyrimidine Dehydrogenase GenotypingTeresa Magnes, Thomas Melchardt, Lukas Weiss, et al.
Antiviral Therapy|December 25, 2009
Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individualsNinon Taylor, Ilse Schmid, Alexander Egle, et al.
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Cancer Treatment Reviews|August 20, 2018
Remission maintenance treatment options in chronic lymphocytic leukemiaAlexander Egle, Lisa Pleyer, Thomas Melchardt, et al.
Cell Cycle (Georgetown, Tex.)|June 29, 2010
Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemiaOlaf Merkel, Daniela Asslaber, Josefina D Piñón, et al.
Discovery Medicine|October 17, 2009
Novel therapeutics approaches to chronic lymphocytic leukemia based on recent biological insightsTanja N Hartmann, Lisa Pleyer, Petra Desch, et al.
Blood|August 28, 2014
How does lenalidomide target the chronic lymphocytic leukemia microenvironment?Arnon P Kater, Sanne H Tonino, Alexander Egle, et al.
Cancer|April 28, 2011
Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemiaLukas Weiss, Thomas Melchardt, Alexander Egle, et al.
Wiener Klinische Wochenschrift|December 7, 2010
An uncommon cause of anaemia: Sheehan's syndromeThomas Melchardt, Konrad Namberger, Lukas Weiss, et al.
Blood|November 25, 2003
VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasiaAlexander Egle, Alan W Harris, Mary L Bath, et al.
Annals of Hematology|December 28, 2012
Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patientNinon Taylor, Thomas Melchardt, Michael Grundbichler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Fluorouracil and Dihydropyrimidine Dehydrogenase GenotypingTeresa Magnes, Thomas Melchardt, Lukas Weiss, et al.
Antiviral Therapy|December 25, 2009
Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individualsNinon Taylor, Ilse Schmid, Alexander Egle, et al.
Pageof 13